Literature DB >> 6383210

Enhanced killing of Candida albicans by cultured peritoneal exudate cells treated with SM-1213, a synthetic immunomodulator.

C J Morrison, P Gordon, T Hashimoto.   

Abstract

The effect of SM-1213 [1,2-O-isopropylidene-3-O-3'-(N', N'-dimethylamino-n-propyl)-D-glucofuranose] on the candidastatic and candidacidal capacity of guinea pig peritoneal exudate cells was investigated. Phagocytes treated with SM-1213 demonstrated an enhanced ability to inhibit intracellular hyphal formation and elongation of Candida albicans cells as well as to reduce the percentage of viable cells remaining after phagocytosis. Significant drug-induced anticandidal effects were also observed when peritoneal exudate cells were preincubated with SM-1213 and washed before infection with C. albicans. SM-1213 had no direct anticandidal effect against the yeast or hyphal form of the fungus, suggesting that the observed candidastatic and candidacidal effect of this drug was due to the enhancement of antimicrobial functions of phagocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383210      PMCID: PMC179920          DOI: 10.1128/AAC.26.1.74

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro.

Authors:  J W Hadden; A Englard; J R Sadlik; E M Hadden
Journal:  Int J Immunopharmacol       Date:  1979

Review 2.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

3.  Enhanced host defense mechanisms with levamisole in suckling rats.

Authors:  G W Fischer; J K Podgore; J W Bass; J L Kelley; G Y Kobayaski
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

4.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

5.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils.

Authors:  T Arai; Y Mikami; K Yokoyama
Journal:  Sabouraudia       Date:  1977-07

8.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.

Authors:  C F Nathan; S C Silverstein; L H Brukner; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  3 in total

1.  Effects of amiprilose hydrochloride on the components of human skin equivalents.

Authors:  J C Hevelone; S D Dimitrijevich; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

2.  Inhibition of psoriatic cell proliferation in in vitro skin models by amiprilose hydrochloride.

Authors:  M L Chapman; S D Dimitrijevich; J C Hevelone; D Goetz; J Cohen; G E Wise; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

3.  In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium.

Authors:  T Hashimoto
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.